Cyclosporine and Infliximab as Rescue Therapy for Each Other in Patients With Steroid-Refractory Ulcerative Colitis

Clinical Gastroenterology and Hepatology

Volumn 6, Issue 10, 2008, Pages 1112-1116

  Maser, Elana A ^a   Deconda, Deepthi ^a   Lichtiger, Simon ^a   Ullman, Thomas ^a   Present, Daniel H ^a   Kornbluth, Asher ^a  

^a MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; INFLIXIMAB; MERCAPTOPURINE; PREDNISONE; STEROID;

ADULT; ARTICLE; BACTEREMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ESOPHAGITIS; FATIGUE; FEMALE; HERPETIC ESOPHAGITIS; HUMAN; LEG CRAMP; LIMB WEAKNESS; MALE; PANCREATITIS; REMISSION; RETROSPECTIVE STUDY; SALVAGE THERAPY; SEPSIS; SKIN TINGLING; TREATMENT FAILURE; TREATMENT OUTCOME; ULCERATIVE COLITIS;

ANTIBODIES, MONOCLONAL; BACTEREMIA; COLITIS, ULCERATIVE; CYCLOSPORINE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; PANCREATITIS; RETROSPECTIVE STUDIES; SALVAGE THERAPY; SEPSIS; TREATMENT OUTCOME;

EID: 52949131525     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2008.04.035     Document Type: Article

References (16)

1. Actis GC, Fadda M, David E, et al. Colectomy rate in steroid-refractory colitis initially responsive to cyclosporin: a long-term retrospective cohort study. BMC Gastroenterol 20077:13.
2. Cohen R.D., Stein R., and Hanauer S.B. Intravenous cyclosporin in ulcerative colitis: a five-year experience. Am J Gastroenterol 94 (1999) 1587-1592
3. Lichtiger S., and Present D.H. Preliminary report: cyclosporin in treatment of severe active ulcerative colitis. Lancet 336 (1990) 16-19
4. Lichtiger S., Present D.H., Kornbluth A., et al. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 330 (1994) 1841-1845
5. Weber A., Fein F., Koch S., et al. Treatment of ulcerative colitis refractory to steroid therapy by oral microemulsion cyclosporine (neoral). Inflamm Bowel Dis 12 (2006) 1131-1135
6. Van Assche G., D'Haens G., Noman M., et al. Randomized, double-blind comparison of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitis. Gastroenterology 125 (2003) 1025-1031
7. Kornbluth A., Sachar D.B., and Practice Parameters Committee of the American College of Gastroenterology. Ulcerative colitis practice guidelines in adults (update): American college of gastroenterology, practice parameters committee. Am J Gastroenterol 99 (2004) 1371-1385
8. Jarnerot G., Hertervig E., Friis-Liby I., et al. Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study. Gastroenterology 128 (2005) 1805-1811
9. Maser E.A., Villela R., Silverberg M.S., et al. Association of trough serum infliximab to clinical outcome after scheduled maintenance treatment for Crohn's disease. Clin Gastroenterol Hepatol 4 (2006) 1248-1254
10. Ptachcinski R.J., Venkataramanan R., Burckart G.J., et al. Cyclosporine kinetics in healthy volunteers. J Clin Pharmacol 27 (1987) 243-248
11. Lam E.C., and Bailey R.J. Infliximab salvage therapy after cyclosporine in an acute flair of chronic ulcerative colitis. Can J Gastroenterol 17 (2003) 198
12. Peto R., and Peto J. Asymptomatically efficient rank invariant test procedures. J R Stat Soc [Ser A] 135 (1972) 185-207
13. Lovegrove R.E., Heriot A.G., Constantinides V., et al. Meta-analysis of short-term and long-term outcomes of J, W and S ileal reservoirs for restorative proctocolectomy. Colorectal Dis 9 (2007) 310-320
14. Rutgeerts P., Sandborn W.J., Feagan B.G., et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med 353 (2005) 2462-2476
15. Kohn A., Daperno M., Armuzzi A., et al. Infliximab in severe ulcerative colitis: short-term results of different infusion regimens and long-term follow-up. Aliment Pharmacol Ther 26 (2007) 747-756
16. Lees C.W., Heys D., Ho G.T., et al., Scottish Society of Gastroenterology Infliximab Group. A retrospective analysis of the efficacy and safety of infliximab as rescue therapy in acute severe ulcerative colitis. Aliment Pharmacol Ther 26 (2007) 411-419